Financial Performance Expectations - The company expects a net profit attributable to shareholders of approximately RMB 200 million to RMB 230 million for 2024, compared to a loss of RMB 322.65 million in the same period last year[3]. - The net profit after deducting non-recurring gains and losses is projected to be between RMB 120 million and RMB 150 million, compared to a loss of RMB 388.28 million in the previous year[3]. - The company's main business revenue is expected to grow by approximately 10% to 15% in 2024, with an improvement in gross profit margin[6]. - The net cash flow from operating activities is estimated to be around RMB 700 million for the reporting period[6]. - Non-recurring gains and losses for 2024 are expected to be about RMB 80 million, primarily from government subsidies[6]. - The company anticipates a goodwill impairment of approximately RMB 30 million to RMB 40 million for the reporting period[6]. Subsidiary Performance - The subsidiary, Hangzhou Puyue Technology, achieved a revenue growth of approximately 20% compared to 2023, with a profit of about RMB 150 million[7]. Strategic Focus and Cost Management - The company plans to focus on high-end analytical instruments and related products, optimizing resources and reducing non-profitable business lines[5]. - The company has implemented cost control measures, resulting in a decrease in various expense amounts[6]. Future Reporting - The specific financial data for 2024 will be detailed in the annual report after evaluation and audit by professional institutions[8].

证券代码：300203 证券简称：聚光科技 公告编号：2024-040 聚光科技（杭州）股份有限公司 关于审计机构变更项目质量控制复核人的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 聚光科技（杭州）股份有限公司（以下简称"公司"或"聚光科技"）分别 于2024年4月21日召开第四届董事会第十三次会议及第四届监事会第十次会议、 于2024年5月15日召开2023年年度股东大会，审议通过了《关于续聘公司2024年 度审计机构的议案》，同意续聘中审众环会计师事务所（特殊普通合伙）（以下 简称"中审众环"）为公司2024年度审计机构。具体内容详见公司分别于2024年4 月23日、2024年5月15日在巨潮资讯网（http://www.cninfo.com.cn）披露的《关 于续聘会计师事务所的公告》等相关公告。 | 时间 | 上市公司名称 | 职务 | | --- | --- | --- | | 2022-2023 年 | 浙江乔治白服饰股份有限公司 | 质量控制复核人 | | 2023 年 | 宁波一彬电子科技股份有限公司 | 质量控制复核人 | | 2023 ...

证券代码：300203 证券简称：聚光科技 公告编号：2024-039 聚光科技（杭州）股份有限公司 关于公司及子公司获得政府补助的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 一、获得补助的基本情况 聚光科技（杭州）股份有限公司（以下简称"公司"、"聚光科技"）及子 公司自 2024 年 09 月 03 日至 2024 年 12 月 04 日累计收到各项政府补助资金共计 人民币 66,608,321.60 元，其中增值税即征即退资金为人民币 23,032,436.40 元，与公司日常经营活动密切相关，具有可持续性；其他政府补助资金为人民币 43,575,885.20 元。现将具体情况分别列示如下： | 获得补助的 | 提供补 助的主 | 项目 | 本期收到补助 | 本期收到补助的 | 补助 | 会计 | | --- | --- | --- | --- | --- | --- | --- | | 主体 | | | 时间 | 金额 | 类型 | 处理 | | | 体 | | | | | | | 杭州谱育科 | 中国 21 世纪议 | 抗振动分子 泵在便携桌 面 ...

聚光科技(杭州)股份有限公司(下称"公司")董事会于2024年11月20日以电 子邮件、书面传真和专人送达等方式发出召开公司第四届董事会第十七次会议通 知。会议于2024年11月25日以通讯表决的方式召开, 本次会议应出席会议的董事 5人,实际出席会议的董事5人。本次会议的召开符合《中华人民共和国公司法》 和公司章程的有关规定，会议决议合法、有效。经与会董事认真讨论，审议通过 了以下议案： 一、审议通过了《关于追加2024年度日常关联交易预计额度的议案》 根据实际经营发展的需要，公司拟追加与浙江红谱科技股份有限公司（以下 简称"红谱科技"）2024年度日常关联交易预计额度，原预计金额为10,000万元， 本次追加5,000万元，本次追加预计额度后，预计公司及子公司2024年度与红谱 科技发生的日常关联交易总额度为15,000万元，其中向红谱科技销售仪器、耗材 等额度由原预计金额5,000万元追加为10,000万元；向红谱科技采购仪器、耗材 等额度为5,000万元，保持不变。具体内容详见中国证监会创业板指定信息披露 网站同期披露的《关于追加2024年度日常关联交易预计额度的公告》，本议案已 经公司第四届董事会第 ...

证券代码：300203 证券简称：聚光科技 公告编号：2024-038 聚光科技（杭州）股份有限公司 关于追加2024年度日常关联交易预计额度的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 一、追加2024年度日常关联交易预计额度的基本情况 (一)追加日常关联交易概述 聚光科技（杭州）股份有限公司（以下简称"公司"）分别于2024年4月21日、 2024年5月15日召开第四届董事会第十三次会议及2023年年度股东大会，审议通 过了《关于2024年度日常关联交易预计的议案》，对公司及下属子公司与关联方 2024年度日常关联交易情况进行了预计，具体内容详见中国证监会创业板指定信 息披露网站同期披露的《关于2024年度日常关联交易预计的公告》（公告编号： 2024-013）。 住所：浙江省湖州市长兴县太湖街道高铁路669号综合楼507室 现根据实际经营发展的需要，公司拟追加与浙江红谱科技股份有限公司（以 下简称"红谱科技"）2024年度日常关联交易预计额度，原预计金额为10,000 万元，本次追加5,000万元，本次追加预计额度后，预计公司及子公司2024年 ...

证券代码：300203 证券简称：聚光科技 公告编号：2024-036 聚光科技（杭州）股份有限公司 关于控股股东部分股份被冻结及轮候冻结的公告 控股股东之一浙江睿洋科技有限公司保证向本公司提供的信息 内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 特别风险提示： 截至本公告披露日，聚光科技（杭州）股份有限公司（以下简称"公司"） 控股股东之一浙江睿洋科技有限公司（以下简称"睿洋科技"）共计持有公司 股份63,520,733股，占公司总股本比例为14.16%。累计被冻结股份数量 52,220,733股，占其所持有公司股份数量比例82.21%，占公司总股本的11.64%； 累计被轮候冻结股份数量10,154,000股，占其所持有公司股份数量比例15.99%， 占公司总股本的2.26%。目前睿洋科技所持有的公司股份82.21%处于冻结状态， 若后续被司法冻结的股份被司法强制处置，将影响睿洋科技的控股股东及王健 先生的实际控制人地位。公司届时可能面临控制权不稳定或变更的风险。 公司于近日接到公司控股股东之一睿洋科 ...

证券代码：300203 证券简称：聚光科技 公告编号：2024-034 聚光科技（杭州）股份有限公司 股份种类（A 股、B 股 等） 减持股数（股） 减持比例（%） 睿洋科技（A 股） 6,073,452 1.35 合计 6,073,452 1.35 本次权益变动方式（可 多选） 通过证券交易所的集中交易 □ 协议转让 □ 通过证券交易所的大宗交易 □ 间接方式转让 □ 国有股行政划转或变更 □ 执行法院裁定 取得上市公司发行的新股 □ 继承 □ 赠与 □ 表决权让渡 □ 其他 □（请注明） 3.本次变动前后，投资者及其一致行动人拥有上市公司权益的股份情况 股份性质 本次变动前持有股份 本次变动后持有股份 股数(股) 占总股本比 例(%) 股数(股) 占总股本比例 (%) 合计持有股份 123,415,785 27.50 117,342,333 26.15 其中：无限售条件股份 123,415,785 27.50 117,342,333 26.15 有限售条件股份 0 0 0 0 4.承诺、计划等履行情况 本次变动是否为履 行已作出的承诺、 意向、计划 是□否 本次变动是否存在 违反《证券法》《上 市公司购买 ...

Investment Rating - The report maintains a "Buy" rating for the company, reflecting confidence in its future performance and market position [3][5] Core Views - The company's Q3 2024 performance exceeded expectations, with revenue reaching 2.31 billion yuan (yoy +12.3%) and net profit attributable to shareholders of 120 million yuan (yoy +166.8%) [1] - Strategic adjustments, including business and product structure optimization, have significantly improved profitability and operational efficiency [1] - The company is focusing on high-end scientific instruments, which are expected to drive future growth [2] Financial Performance - Gross margin for the first three quarters of 2024 reached 44.4% (yoy +2.7pct), while net margin was 4.9% (yoy +15.5pct) [2] - Operating cash flow improved significantly, with a net inflow of 78.86 million yuan, an increase of 410 million yuan compared to the same period last year [2] - The company has reduced its expense ratios, with sales expense ratio at 18.8% (-3.9pct), management expense ratio at 9.1% (-1.4pct), and R&D expense ratio at 13.5% (-8.0pct) [2] Business Strategy - The company is optimizing its business layout, focusing on high-end scientific instruments and life science instruments [2] - It has stopped signing new PPP contracts and is gradually divesting from some PPP projects [2] - The company is strengthening its R&D capabilities, with several products reaching international advanced levels and achieving import substitution [3] Future Projections - Revenue is expected to grow to 3.6 billion yuan in 2024, 4.25 billion yuan in 2025, and 5.33 billion yuan in 2026 [3] - Net profit attributable to shareholders is projected to be 210 million yuan in 2024, 280 million yuan in 2025, and 420 million yuan in 2026 [3] - The company's PE ratio is forecasted to be 38.9x in 2024, 28.0x in 2025, and 18.9x in 2026 [3] Product Development - The company's subsidiary, Puyu Technology, has developed China's first quadrupole time-of-flight high-resolution mass spectrometer, which is now being marketed [3] - The high-end mass spectrometer and life science instrument product matrix is expected to accelerate the localization of high-level scientific research equipment [3] Market Position - The company is a leading domestic player in high-end analytical instruments, with several products breaking foreign monopolies [3] - Its R&D capabilities are industry-leading, and the company is expected to continue increasing its market share in the high-end analytical instrument sector [3]

Financial Performance - The company's revenue for Q3 2024 reached ¥894,697,144.70, representing a 5.12% increase year-over-year[2] - Net profit attributable to shareholders was ¥72,094,970.10, a significant increase of 285.65% compared to the same period last year[2] - The net profit after deducting non-recurring gains and losses was ¥55,336,809.23, up 225.04% year-over-year[2] - The basic earnings per share for the period was ¥0.161, reflecting an increase of 284.67% compared to the previous year[2] - Total operating revenue for Q3 2024 reached ¥2,305,366,010.42, an increase of 12.2% compared to ¥2,052,258,372.90 in the same period last year[15] - The net profit for the third quarter of 2024 was ¥111,848,795.94, a significant recovery from a net loss of ¥218,569,393.32 in the same period last year, marking a turnaround of over 151%[16] - The basic and diluted earnings per share for the third quarter were both ¥0.262, recovering from a loss of ¥0.393 per share in the same quarter last year[17] - The total profit for the quarter was ¥119,872,219.01, compared to a total loss of ¥255,944,149.78 in the same quarter last year[16] Assets and Liabilities - Total assets at the end of the reporting period were ¥9,392,456,929.79, a decrease of 3.32% from the end of the previous year[2] - Total assets decreased to ¥9,392,456,929.79 from ¥9,715,376,558.83, a reduction of 3.3%[14] - Total liabilities decreased to ¥6,120,410,875.72 from ¥6,554,483,630.66, a decline of 6.6%[14] - The company’s total equity increased to ¥3,272,046,054.07 from ¥3,160,892,928.17, an increase of 3.5%[14] - The total equity attributable to shareholders increased by 4.05% to ¥3,026,654,077.52 compared to the end of the previous year[2] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥78,862,667.55, showing a 123.95% increase compared to the same period last year[8] - The cash flow from operating activities generated a net inflow of ¥78,862,667.55, a significant improvement from a net outflow of ¥329,247,654.83 in the previous year[18] - The company reported a net cash outflow from financing activities of ¥194,723,632.50, a significant increase of 648.64% compared to the previous year[8] - The company’s cash inflow from financing activities was ¥1,169,133,545.58, while cash outflow was ¥1,363,857,178.08, resulting in a net cash outflow of ¥194,723,632.50[19] - The company reported a net cash outflow from investing activities of ¥52,958,683.03, an improvement from a net outflow of ¥84,952,297.68 in the same period last year[19] Shareholder Information - The total number of common shareholders at the end of the reporting period is 17,383[9] - Zhejiang Ruiyang Technology Co., Ltd. holds 15.33% of shares, totaling 68,780,733 shares[9] - Zhejiang Pudu Technology Co., Ltd. holds 11.55% of shares, totaling 51,821,600 shares[9] - The largest foreign shareholder, Island Honour Limited, holds 2.87% of shares, totaling 12,885,900 shares[9] - The total number of restricted shares at the beginning of the period was 262,500, with 106,575 shares added during the period[11] - The total number of unrestricted circulating shares held by the top ten shareholders is 68,780,733 shares[10] - The company has not disclosed any related party relationships among the top shareholders[10] - The company has a total of 0 preferred shareholders and no preferred shares held by the top ten shareholders[11] - The company has not reported any changes in the top ten shareholders due to securities lending or borrowing[10] - The company has a total of 369,075 restricted shares at the end of the period[11] Operating Costs and Expenses - Total operating costs decreased to ¥2,377,956,712.16 from ¥2,468,000,530.38, reflecting a reduction of 3.7%[15] - Research and development expenses decreased by 29.51% year-over-year, amounting to ¥311,207,645.74[7] - Research and development expenses for the quarter were ¥311,207,645.74, down 29.5% from ¥441,510,604.38 in the previous year[15] - The company's cash and cash equivalents decreased to ¥1,009,241,750.06 from ¥1,255,880,865.89, a decline of 19.6%[12] - Accounts receivable increased to ¥929,789,084.11, up 2.0% from ¥904,907,593.54 at the beginning of the period[12] - Inventory rose to ¥1,415,984,405.58, an increase of 3.0% compared to ¥1,373,751,754.01 at the start of the quarter[12] Investment Income - Investment income increased by 107.98% year-over-year, reaching ¥81,499,764.95 due to profit growth from joint ventures[7]

控股股东之一浙江睿洋科技有限公司保证向本公司提供的信息 内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 证券代码：300203 证券简称：聚光科技 公告编号：2024-030 聚光科技（杭州）股份有限公司 关于控股股东部分股份被冻结的公告 技 持 有 本 公 司 的 5,260,000 股 股 份 进 行 司 法 拍 卖 ， 具 体 情 况 内 容 详 见 拍卖平台 "https://sf.taobao.com"公示的《网络竞价成功确认书》，上述司法拍卖尚未完成过户， 拍卖结果尚存在不确定性，本次拍卖不会导致本公司控制权发生变更。公司将持续关注上述 事项的进展，按照法律法规要求及时履行信息披露义务，并配合相关信息披露义务人履行披 露义务。 三、其他说明及风险提示 1、睿洋科技此次被司法冻结的658.40万股股票为睿洋科技因融资担保质押 给杭州工商信托股份有限公司的股票，详见本公司分别于2022年12月22日披露的 《关于控股股东办理质押回购业务、部分解除质押业务及部分股份被冻结的公 告》（公告编号2022- ...